Five Democrats voted with all of the panel's Republicans in opposing the inclusion of the government-run option in the bill in what is expected to be the first of several battles in Congress over the public option. Read Summary >
Drugmaker Opexa says their experimental drug Tovaxin helped 83 percent of patients with relapsing remitting multiple sclerosis remain relapse free after a year. Read Summary >
The new information warns patients that the risk of progressive multifocal leukoencephalopathy, or PML, appears to increase as the number of Tysabri infusions increase. Read Summary >
A new drug called atacicept that is being developed to treat rheumatoid arthritis has failed to meet its goals in mid-stage clinical trials, its maker reports. Read Summary >
